Published in J Cell Biol on January 01, 1994
CD44 cell adhesion molecules. Mol Pathol (1999) 2.89
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J (1998) 1.93
The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J (2001) 1.92
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J (2001) 1.83
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol (1995) 1.65
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm (2008) 1.45
The normal structure and function of CD44 and its role in neoplasia. Mol Pathol (1998) 1.44
RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol (2001) 1.41
ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer. BMC Genomics (2016) 1.39
Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med (2000) 1.31
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis (2007) 1.29
Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis (2006) 1.26
CD44 in inflammation and metastasis. Glycoconj J (1997) 1.16
Trans-acting factors regulate the expression of CD44 splice variants. EMBO J (1996) 1.15
Forms and functions of CD44. Immunology (1998) 1.15
Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol (2004) 1.12
CD44 and the adhesion of neoplastic cells. Mol Pathol (1997) 1.12
CD44 functions in Wnt signaling by regulating LRP6 localization and activation. Cell Death Differ (2014) 1.09
Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism. J Virol (1995) 1.05
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum (2010) 1.04
Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface. J Immunol (2010) 1.03
Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. Clin Cancer Res (2013) 1.01
Transmigrated neutrophils in the intestinal lumen engage ICAM-1 to regulate the epithelial barrier and neutrophil recruitment. Mucosal Immunol (2013) 1.00
Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer (1995) 1.00
Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol (1996) 0.98
Clathrin-independent endocytosis: a cargo-centric view. Exp Cell Res (2013) 0.97
Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol (1996) 0.96
Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut (2000) 0.95
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut (1996) 0.95
Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis. Rheumatol Int (1997) 0.91
Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2004) 0.90
Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol (1996) 0.90
Expression of adhesion molecule CD44 on human corneas. Br J Ophthalmol (1997) 0.89
Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem (2011) 0.89
Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Arch Gynecol Obstet (1996) 0.87
Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. Clin Mol Pathol (1995) 0.87
Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene. Clin Mol Pathol (1995) 0.86
CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am J Pathol (1998) 0.86
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells. J Drug Deliv (2013) 0.85
Expression of CD44 by rhabdomyosarcoma: a new prognostic marker? Br J Cancer (1999) 0.84
Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells. PLoS One (2012) 0.83
Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma. Gut Liver (2011) 0.83
Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). J Proteome Res (2012) 0.83
Tip110 interacts with YB-1 and regulates each other's function. BMC Mol Biol (2013) 0.81
Phototheranostics of CD44-positive cell populations in triple negative breast cancer. Sci Rep (2016) 0.81
Expression of CD44 on rheumatoid synovial fluid lymphocytes. Ann Rheum Dis (1995) 0.80
OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction. J Clin Pathol (1996) 0.80
Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo. Oncotarget (2015) 0.80
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studies. MAbs (2013) 0.80
Prognostic significance of CD44 expression in adenocarcinoma of the lung. Clin Mol Pathol (1995) 0.79
Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion. PLoS One (2015) 0.79
Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis. Vet Microbiol (2006) 0.79
The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas. Br J Cancer (2001) 0.78
Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. J Control Release (2015) 0.78
Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma. Int Rev Immunol (2012) 0.78
CD44 expression in curettage and postoperative specimens of endometrial cancer. Arch Gynecol Obstet (2014) 0.77
Antibody Drug Conjugates: Nonclinical Safety Considerations. AAPS J (2015) 0.77
Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of adhesion molecule CD44. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.76
The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. Am J Pathol (1995) 0.76
CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination. Oncotarget (2015) 0.76
Differential CD44 expression patterns in primary brain tumours and brain metastases. Br J Cancer (1995) 0.76
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives. Respir Res (2017) 0.75
Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v). J Clin Pathol (1996) 0.75
Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction. Oncol Lett (2015) 0.75
The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice. Cancer Lett (2015) 0.75
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer (1998) 0.75
Expression of CD44 in human neoplastic and normal hyaline cartilage. Iowa Orthop J (2002) 0.75
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today (2016) 0.75
Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies. Oncotarget (2016) 0.75
Alteration of the expression of CD44 [corrected] isoforms in oral epithelia and saliva from patients with oral lichen planus. J Clin Immunol (2007) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Adhesion receptors of the immune system. Nature (1990) 28.86
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01
Antigen-specific interaction between T and B cells. Nature (1985) 10.64
The pathophysiology of tumor necrosis factors. Annu Rev Immunol (1992) 8.38
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol (1993) 6.33
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A (1992) 4.90
Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am J Anat (1974) 4.61
T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature (1993) 4.57
A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell (1989) 4.39
CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 4.04
Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol (1987) 3.84
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med (1990) 3.78
Proteoglycans: many forms and many functions. FASEB J (1992) 3.57
The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J (1991) 3.20
Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet (1992) 3.16
Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (1992) 3.05
CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunol Today (1989) 2.96
Homing of naive, memory and effector lymphocytes. Curr Opin Immunol (1993) 2.93
Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem (1988) 2.72
Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med (1993) 2.67
Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol (1991) 2.57
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol (1992) 2.52
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res (1991) 2.36
The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol (1990) 2.32
Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol (1989) 2.24
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol (1992) 2.15
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol (1993) 2.06
Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med (1993) 2.03
Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem (1992) 2.03
Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J Cell Biol (1993) 1.96
Selective migration of terminally differentiating cells from the basal layer of cultured human epidermis. J Cell Biol (1984) 1.93
Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J Cell Biol (1989) 1.88
The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells (1991) 1.85
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet (1993) 1.80
Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med (1993) 1.77
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med (1991) 1.55
A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol (1986) 1.54
Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol (1992) 1.47
The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol (1992) 1.46
Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med (1993) 1.40
Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol (1993) 1.34
The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol (1989) 1.33
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res (1993) 1.28
Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol (1992) 1.27
A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res (1993) 1.26
Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology (1989) 1.23
Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res (1989) 1.18
The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44. Biochem Biophys Res Commun (1992) 1.16
Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res (1991) 1.14
Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer (1990) 1.11
Progenitor cells in the thymus: most thymus-homing progenitor cells in the adult mouse thymus bear Pgp-1 glycoprotein but not interleukin-2 receptor on their cell surface. Cell Immunol (1986) 1.06
Characterization of a 95,000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology (1988) 1.06
Tumour invasion: effects of cell adhesion and motility. Trends Cell Biol (1992) 1.03
Adult human keratinocytes migrating over nonviable dermal collagen produce collagenolytic enzymes that degrade type I and type IV collagen. J Invest Dermatol (1986) 0.94
Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol (1991) 0.90
Tumor and host molecules important in the organ preference of metastasis. Semin Cancer Biol (1991) 0.90
Tumour necrosis factor: roles in cancer pathophysiology. Semin Cancer Biol (1992) 0.85
Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med (1990) 5.54
Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86
Homing of naive, memory and effector lymphocytes. Curr Opin Immunol (1993) 2.93
Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol (1999) 2.60
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res (1991) 2.36
Immunological memory. Adv Immunol (1993) 2.34
Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol (1996) 2.27
Reconstruction of the ulnar collateral ligament in athletes. J Bone Joint Surg Am (1986) 2.05
A standarized test of renal concentrating capacity in children. Am J Dis Child (1967) 1.96
T-cell memory: the connection between function, phenotype and migration pathways. Immunol Today (1991) 1.95
Tissue-specific migration pathways by phenotypically distinct subpopulations of memory T cells. Eur J Immunol (1992) 1.82
The Sm domain is an ancient RNA-binding motif with oligo(U) specificity. Proc Natl Acad Sci U S A (2001) 1.81
Early medical use of cannabis. Nature (1993) 1.80
DNA methyltransferases affecting the sequence 5'CCGG. Nucleic Acids Res (1981) 1.80
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta (2001) 1.78
De-novo expression of CD44 and survival in gastric cancer. Lancet (1993) 1.75
Advantages of CCD detectors for de novo three-dimensional structure determination in single-particle electron microscopy. J Struct Biol (2005) 1.75
Restriction and modification in Bacillus subtilis: DNA methylation potential of the related bacteriophages Z, SPR, SP beta, phi 3T, and rho 11. J Virol (1983) 1.72
Gamma/delta T cells express a unique surface molecule appearing late during thymic development. Eur J Immunol (1989) 1.70
High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res (1995) 1.65
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J (2001) 1.64
Migration pathways and immunologic memory among T lymphocytes. Semin Immunol (1992) 1.63
Restriction and modification in Bacillus subtilis: identification of a gene in the temperate phage SP beta coding for a BsuR specific modification methyltransferase. Mol Gen Genet (1980) 1.62
High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature (2000) 1.60
GTPases mechanisms and functions of translation factors on the ribosome. Biol Chem (2000) 1.51
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia (2010) 1.48
CD44 isoforms in prognosis of breast cancer. Lancet (1995) 1.47
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group. Ann Oncol (2009) 1.43
Idiopathic hypercalciuria. Pediatr Nephrol (1991) 1.39
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther (1998) 1.38
Restriction and modification in Bacillus subtilis. Localization of the methylated nucleotide in the BsuRI recognition sequence. Eur J Biochem (1978) 1.37
Automatic CTF correction for single particles based upon multivariate statistical analysis of individual power spectra. J Struct Biol (2003) 1.37
Altered patterns of T cell migration through lymph nodes and skin following antigen challenge. Eur J Immunol (1992) 1.35
Three-dimensional structure of the anaphase-promoting complex. Mol Cell (2001) 1.31
Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med (2000) 1.31
Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol (1998) 1.31
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med (1995) 1.30
A large proportion of bovine T cells express the gamma delta T cell receptor and show a distinct tissue distribution and surface phenotype. Int Immunol (1989) 1.29
Cloning and expression of Bacillus subtilis phage DNA methyltransferase genes in Escherichia coli and B. subtilis. Gene (1986) 1.27
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study. Leukemia (2012) 1.27
Corrim-based alignment for improved speed in single-particle image processing. J Struct Biol (2003) 1.26
A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res (1993) 1.26
Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology (1999) 1.25
DNA methyltransferases of Bacillus subtilis and its bacteriophages. Curr Top Microbiol Immunol (1984) 1.25
Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology. J Pathol (1997) 1.24
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Ann Oncol (2009) 1.22
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood (1995) 1.21
Unusual expression of CD2 in sheep: implications for T cell interactions. Eur J Immunol (1988) 1.21
Fluid transport at low Reynolds number with magnetically actuated artificial cilia. Eur Phys J E Soft Matter (2009) 1.20
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res (2001) 1.19
Cell adhesion in the immune system. Immunol Today (1993) 1.19
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut (2008) 1.19
CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res (1995) 1.18
Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy. FEBS Lett (1999) 1.16
CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry (1994) 1.16
CD44 isoforms during differentiation and development. Bioessays (1995) 1.15
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology (1998) 1.15
Restriction and modification in Bacillus subtilis: two DNA methyltransferases with BsuRI specificity. I. Purification and physical properties. J Biol Chem (1981) 1.15
A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ (2006) 1.14
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism Relat Disord (2005) 1.13
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol (2000) 1.12
Correlation of the expansion segments in mammalian rRNA with the fine structure of the 80 S ribosome; a cryoelectron microscopic reconstruction of the rabbit reticulocyte ribosome at 21 A resolution. J Mol Biol (1998) 1.12
Adenocarcinoma of the ileoanal pouch for ulcerative colitis--a complication of severe chronic atrophic pouchitis? Int J Colorectal Dis (2005) 1.12
Restriction and modification in Bacillus subtilis: two DNA methyltransferases with BsuRI specificity. II. Catalytic properties, substrate specificity, and mode of action. J Biol Chem (1981) 1.11
Multispecific DNA methyltransferases from Bacillus subtilis phages. Properties of wild-type and various mutant enzymes with altered DNA affinity. Eur J Biochem (1986) 1.11
Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer (1990) 1.11
Are CD44 variant isoforms involved in human tumour progression? Cancer Surv (1995) 1.10
Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol (2000) 1.10
Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy (2002) 1.10
Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin. Blood (1997) 1.07
In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res (2000) 1.06
Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. Allergy (2008) 1.05
Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. J Immunol (1998) 1.05
Restriction and modification in B. subtilis. The biochemical basis of modification against endo R. Bsu R restriction. Mol Gen Genet (1975) 1.05
Directional variation in extensibility of human skin in vivo. J Biomech (1969) 1.03
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. J Pharmacol Exp Ther (1994) 1.02
Bacillus subtilis phage SPR codes for a DNA methyltransferase with triple sequence specificity. Nucleic Acids Res (1987) 1.01
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther (2006) 1.01
Image restoration by the method of convex projections: part 2 applications and numerical results. IEEE Trans Med Imaging (1982) 1.00
The randomized shortened dental arch study: tooth loss over five years. Clin Oral Investig (2012) 0.99
Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther (2000) 0.99
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform. Eur J Clin Invest (2008) 0.98
Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol (1993) 0.97
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood (1998) 0.97
Unusual behaviour of SPO1 DNA with respect to restriction and modification enzymes recognizing the sequence 5'-G-G-C-C. Mol Gen Genet (1980) 0.96
The 80S rat liver ribosome at 25 A resolution by electron cryomicroscopy and angular reconstitution. Structure (1998) 0.96
Spiral sampling in magnetic resonance imaging-the effect of inhomogeneities. IEEE Trans Med Imaging (1987) 0.96
Restriction and modification in Bacillus subtilis: gene coding for a BsuR-specific modification methyltransferase in the temperate bacteriophage phi 3T. J Virol (1981) 0.95
The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Ann Hematol (2014) 0.94
Motor-driven bacterial flagella and buckling instabilities. Eur Phys J E Soft Matter (2012) 0.94